vs

Side-by-side financial comparison of GLAUKOS Corp (GKOS) and Knowles Corp (KN). Click either name above to swap in a different company.

Knowles Corp is the larger business by last-quarter revenue ($153.1M vs $150.6M, roughly 1.0× GLAUKOS Corp). Knowles Corp runs the higher net margin — 6.3% vs 6.2%, a 0.1% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 22.7%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs -13.5%).

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

Knowles Corporation is a global leading designer and manufacturer of advanced micro-acoustic, audio processing, and precision component solutions. It serves core segments including consumer electronics, automotive, medical technology, and industrial markets, offering products such as MEMS microphones, hearing aid components, and edge audio processing ICs to worldwide clients.

GKOS vs KN — Head-to-Head

Bigger by revenue
KN
KN
1.0× larger
KN
$153.1M
$150.6M
GKOS
Growing faster (revenue YoY)
GKOS
GKOS
+18.5% gap
GKOS
41.2%
22.7%
KN
Higher net margin
KN
KN
0.1% more per $
KN
6.3%
6.2%
GKOS
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
-13.5%
KN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
GKOS
GKOS
KN
KN
Revenue
$150.6M
$153.1M
Net Profit
$9.4M
$9.7M
Gross Margin
77.9%
43.8%
Operating Margin
9.0%
10.4%
Net Margin
6.2%
6.3%
Revenue YoY
41.2%
22.7%
Net Profit YoY
585.0%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GKOS
GKOS
KN
KN
Q1 26
$150.6M
$153.1M
Q4 25
$143.1M
$162.2M
Q3 25
$133.5M
$152.9M
Q2 25
$124.1M
$145.9M
Q1 25
$106.7M
$132.2M
Q4 24
$105.5M
$142.5M
Q3 24
$96.7M
$142.5M
Q2 24
$95.7M
$204.7M
Net Profit
GKOS
GKOS
KN
KN
Q1 26
$9.4M
$9.7M
Q4 25
$-133.7M
$21.0M
Q3 25
$-16.2M
$17.4M
Q2 25
$-19.7M
$7.8M
Q1 25
$-18.1M
$-2.0M
Q4 24
$-33.6M
$18.5M
Q3 24
$-21.4M
$500.0K
Q2 24
$-50.5M
$-259.3M
Gross Margin
GKOS
GKOS
KN
KN
Q1 26
77.9%
43.8%
Q4 25
-1.1%
44.7%
Q3 25
78.4%
45.7%
Q2 25
78.3%
41.5%
Q1 25
77.2%
40.3%
Q4 24
72.9%
42.7%
Q3 24
76.6%
44.1%
Q2 24
76.4%
28.2%
Operating Margin
GKOS
GKOS
KN
KN
Q1 26
9.0%
10.4%
Q4 25
-97.7%
15.9%
Q3 25
-12.3%
16.9%
Q2 25
-18.3%
10.1%
Q1 25
-19.4%
3.0%
Q4 24
-27.2%
10.8%
Q3 24
-25.5%
13.1%
Q2 24
-31.3%
6.2%
Net Margin
GKOS
GKOS
KN
KN
Q1 26
6.2%
6.3%
Q4 25
-93.4%
12.9%
Q3 25
-12.2%
11.4%
Q2 25
-15.8%
5.3%
Q1 25
-17.0%
-1.5%
Q4 24
-31.8%
13.0%
Q3 24
-22.1%
0.4%
Q2 24
-52.8%
-126.7%
EPS (diluted)
GKOS
GKOS
KN
KN
Q1 26
$0.13
Q4 25
$-2.34
$0.23
Q3 25
$-0.28
$0.20
Q2 25
$-0.34
$0.09
Q1 25
$-0.32
$-0.02
Q4 24
$-0.56
$0.20
Q3 24
$-0.39
$0.01
Q2 24
$-1.00
$-2.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GKOS
GKOS
KN
KN
Cash + ST InvestmentsLiquidity on hand
$276.7M
$41.0M
Total DebtLower is stronger
$131.0M
Stockholders' EquityBook value
$670.9M
$780.2M
Total Assets
$893.3M
$1.1B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GKOS
GKOS
KN
KN
Q1 26
$276.7M
$41.0M
Q4 25
$90.8M
$54.2M
Q3 25
$98.2M
$92.5M
Q2 25
$100.8M
$103.2M
Q1 25
$114.3M
$101.9M
Q4 24
$169.6M
$130.1M
Q3 24
$100.1M
$92.6M
Q2 24
$68.1M
$84.0M
Total Debt
GKOS
GKOS
KN
KN
Q1 26
$131.0M
Q4 25
$114.0M
Q3 25
$176.3M
Q2 25
$190.0M
Q1 25
$188.8M
Q4 24
$202.5M
Q3 24
$225.0M
Q2 24
$261.2M
Stockholders' Equity
GKOS
GKOS
KN
KN
Q1 26
$670.9M
$780.2M
Q4 25
$656.2M
$775.8M
Q3 25
$769.5M
$751.8M
Q2 25
$765.1M
$746.1M
Q1 25
$764.0M
$755.8M
Q4 24
$766.9M
$756.0M
Q3 24
$668.5M
$777.4M
Q2 24
$665.2M
$753.0M
Total Assets
GKOS
GKOS
KN
KN
Q1 26
$893.3M
$1.1B
Q4 25
$893.5M
$1.1B
Q3 25
$999.4M
$1.1B
Q2 25
$987.0M
$1.1B
Q1 25
$966.2M
$1.1B
Q4 24
$974.8M
$1.1B
Q3 24
$926.5M
$1.2B
Q2 24
$919.7M
$1.2B
Debt / Equity
GKOS
GKOS
KN
KN
Q1 26
0.17×
Q4 25
0.15×
Q3 25
0.23×
Q2 25
0.25×
Q1 25
0.25×
Q4 24
0.27×
Q3 24
0.29×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GKOS
GKOS
KN
KN
Operating Cash FlowLast quarter
$0
Free Cash FlowOCF − Capex
$-3.1M
FCF MarginFCF / Revenue
-2.0%
Capex IntensityCapex / Revenue
7.1%
Cash ConversionOCF / Net Profit
0.00×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GKOS
GKOS
KN
KN
Q1 26
$0
Q4 25
$6.8M
Q3 25
$-10.1M
$29.1M
Q2 25
$7.0M
$36.4M
Q1 25
$-18.5M
$1.3M
Q4 24
$507.0K
Q3 24
$-9.6M
$52.8M
Q2 24
$-18.4M
$24.9M
Free Cash Flow
GKOS
GKOS
KN
KN
Q1 26
$-3.1M
Q4 25
$3.9M
Q3 25
$-11.7M
$21.4M
Q2 25
$5.8M
$31.3M
Q1 25
$-20.5M
$-2.7M
Q4 24
$-1.2M
Q3 24
$-11.0M
$49.1M
Q2 24
$-20.5M
$21.7M
FCF Margin
GKOS
GKOS
KN
KN
Q1 26
-2.0%
Q4 25
2.7%
Q3 25
-8.8%
14.0%
Q2 25
4.7%
21.5%
Q1 25
-19.2%
-2.0%
Q4 24
-1.2%
Q3 24
-11.4%
34.5%
Q2 24
-21.4%
10.6%
Capex Intensity
GKOS
GKOS
KN
KN
Q1 26
7.1%
Q4 25
2.0%
9.4%
Q3 25
1.2%
5.0%
Q2 25
0.9%
3.5%
Q1 25
1.8%
3.0%
Q4 24
1.6%
2.3%
Q3 24
1.5%
2.6%
Q2 24
2.2%
1.6%
Cash Conversion
GKOS
GKOS
KN
KN
Q1 26
0.00×
Q4 25
Q3 25
1.67×
Q2 25
4.67×
Q1 25
Q4 24
Q3 24
105.60×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons